tyrosine has been researched along with Hyperpigmentation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carney, BC; Collins, M; Keyloun, JW; Kurup, S; Moffatt, LT; Oliver, MA; Shupp, JW; Travis, TE | 1 |
| Dávid, K; Horváth, G | 1 |
| Ni-Komatsu, L; Orlow, SJ | 1 |
| Matsumoto, K; Nordlund, J; Robb, E; Warden, G | 1 |
1 review(s) available for tyrosine and Hyperpigmentation
| Article | Year |
|---|---|
[Iron storage disease].
Topics: Aspartic Acid; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 6; Cysteine; Diabetes Mellitus; Diagnosis, Differential; Hemochromatosis; Histidine; Humans; Hyperpigmentation; Iron Overload; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Phlebotomy; Point Mutation; Population Surveillance; Prevalence; Prognosis; Tyrosine | 2004 |
3 other study(ies) available for tyrosine and Hyperpigmentation
| Article | Year |
|---|---|
Laser-assisted drug delivery of synthetic alpha melanocyte stimulating hormone and L-tyrosine leads to increased pigmentation area and expression of melanogenesis genes in a porcine hypertrophic scar model.
Topics: alpha-MSH; Animals; Cicatrix, Hypertrophic; Hyperpigmentation; Hypopigmentation; Lasers, Gas; Melanins; Pharmaceutical Preparations; Pigmentation; Swine; Tyrosine | 2023 |
Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content.
Topics: Animals; Antidepressive Agents, Tricyclic; Biological Products; Cells, Cultured; Culture Media; Drug Design; Genetic Testing; Humans; Hyperpigmentation; Intramolecular Oxidoreductases; Lysosomal Membrane Proteins; Melanins; Melanocytes; Membrane Glycoproteins; Mice; Oxidoreductases; Protamines; Transfection; Tyrosine | 2008 |
Hyperpigmentation of human skin grafted on to athymic nude mice: immunohistochemical study.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Dihydroxyphenylalanine; Fluorescent Antibody Technique; Humans; Hyperpigmentation; Intramolecular Oxidoreductases; Isomerases; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Oxidoreductases; Postoperative Complications; Proteins; Skin Transplantation; Transplantation, Heterologous; Tyrosine; Wound Healing | 1996 |